eFFECTOR Therapeutics, Inc. announced that it has closed its previously announced $8.7 million registered direct offering for the purchase and sale of an aggregate of 7,764,445 shares of its common stock, at a purchase price of $1.125 per share, priced at-the-market under Nasdaq rules.
June 8, 2023
· 5 min read
